Determination of fosmidomycin in human serum and urine by capillary electrophoresis

被引:6
作者
Bronner, S
Renault, C
Hintz, M
Wiesner, J
Jomaa, H
Monteil, H
Jehl, F
机构
[1] Univ Strasbourg 1, Inst Bacteriol, Lab Antibiol Bacyerienne, F-67000 Strasbourg, France
[2] Univ Giessen, Ctr Hosp, Inst Biochem, D-35392 Giessen, Germany
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2004年 / 806卷 / 02期
关键词
fosmidomycin;
D O I
10.1016/j.jchromb.2004.04.002
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A capillary electrophoresis method with direct UV detection was developed for the determination of fosmidomycin, a promising new anti-malarial drug. in human serum and urine. Optimization of the separation parameters resulted in a buffer system adjusted to pH 10.8 containing a cationic reagent and an organic modifier. Under these conditions, the migration time of fosmidomycin was 5.2 min with serum and 7.4 min with urine samples. Validation of the method revealed good recoveries, precision and accuracy. The limit of quantification was 0.5 mug/ml in serum and 10 mug/ml in urine. The determination of fosmidomycin in serum was linear over a range of 0.1-150 mug/ml. Short and long-term stability tests resulted in no significant loss of fosmidomycin. The described technique will provide a fast and accurate analytical method for future pharmacokinetic studies. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 17 条
[1]   Fosmidomycin-clindamycin for plasmodium falciparum infections in African children [J].
Borrmann, S ;
Adegnika, AA ;
Matsiegui, PB ;
Issifou, S ;
Schindler, A ;
Mawili-Mboumba, DP ;
Baranek, T ;
Wiesner, J ;
Jomaa, H ;
Kremsner, PG .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05) :901-908
[2]  
BORRMANN S, UNPUB
[3]   Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs [J].
Jomaa, H ;
Wiesner, J ;
Sanderbrand, S ;
Altincicek, B ;
Weidemeyer, C ;
Hintz, M ;
Türbachova, I ;
Eberl, M ;
Zeidler, J ;
Lichtenthaler, HK ;
Soldati, D ;
Beck, E .
SCIENCE, 1999, 285 (5433) :1573-1576
[4]  
KAMIYA T, 1980, Patent No. 4206
[5]  
KUEMMERLE HP, 1987, CHEMIOTERAPIA, V6, P113
[6]   Fosmidomycin, a specific inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis [J].
Kuzuyama, T ;
Shimizu, T ;
Takahashi, S ;
Seto, H .
TETRAHEDRON LETTERS, 1998, 39 (43) :7913-7916
[7]   DETERMINATION OF FOSFOMYCIN IN BIOLOGICAL-FLUIDS BY CAPILLARY ELECTROPHORESIS [J].
LEVEQUE, D ;
GALLION, C ;
TARRAL, E ;
MONTEIL, H ;
JEHL, F .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 655 (02) :320-324
[8]   PHARMACEUTICAL DRUG SEPARATIONS BY HPCE - PRACTICAL GUIDELINES [J].
MCLAUGHLIN, GM ;
NOLAN, JA ;
LINDAHL, JL ;
PALMIERI, RH ;
ANDERSON, KW ;
MORRIS, SC ;
MORRISON, JA ;
BRONZERT, TJ .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1992, 15 (6-7) :961-1021
[9]   Fosmidomycin for malaria [J].
Missinou, MA ;
Borrmann, S ;
Schindler, A ;
Issifou, S ;
Adegnika, AA ;
Matsiegui, PB ;
Binder, R ;
Lell, B ;
Wiesner, J ;
Baranek, T ;
Jomaa, H ;
Kremsner, PG .
LANCET, 2002, 360 (9349) :1941-1942
[10]   PHARMACOKINETICS OF FOSMIDOMYCIN, A NEW PHOSPHONIC ACID ANTIBIOTIC [J].
MURAKAWA, T ;
SAKAMOTO, H ;
FUKADA, S ;
KONISHI, T ;
NISHIDA, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (02) :224-230